KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Change in Account Payables (2016 - 2025)

Teladoc Health's Change in Account Payables history spans 12 years, with the latest figure at -$4.8 million for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 6.38% year-over-year to -$4.8 million; the TTM value through Dec 2025 reached $11.5 million, up 210.51%, while the annual FY2025 figure was $11.5 million, 210.51% up from the prior year.
  • Change in Account Payables for Q4 2025 was -$4.8 million at Teladoc Health, down from -$3.0 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $46.9 million in Q2 2022 and bottomed at -$23.3 million in Q3 2022.
  • The 5-year median for Change in Account Payables is -$3.8 million (2024), against an average of -$1600.0.
  • The largest annual shift saw Change in Account Payables crashed 2288.25% in 2021 before it skyrocketed 547.42% in 2022.
  • A 5-year view of Change in Account Payables shows it stood at $12.3 million in 2021, then crashed by 280.37% to -$22.2 million in 2022, then soared by 178.79% to $17.5 million in 2023, then tumbled by 125.82% to -$4.5 million in 2024, then decreased by 6.38% to -$4.8 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Change in Account Payables are -$4.8 million (Q4 2025), -$3.0 million (Q3 2025), and $1.9 million (Q2 2025).